<PAGE>
As filed with the Securities and Exchange Commission on September 6, 1995
Registration No. 33-57360
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
--------------------------
CARRINGTON LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Texas 75-1435663
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
2001 Walnut Hill Lane
Irving, Texas 75038
(214) 518-1300
(Address, including zip code, and telephone number,
including area code, of registrant's principal executive offices)
--------------------------
CHRISTOPHER S. RECORD
Vice President, Finance and Administration
Carrington Laboratories, Inc.
2001 Walnut Hill Lane
Irving, Texas 75038
(214) 518-1300
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
--------------------------
Copy to:
NORMAN R. ROGERS
Thompson & Knight,
A Professional Corporation
1700 Pacific Avenue, Suite 3300
Dallas, Texas 75201
This Registration Statement shall hereafter become effective in
accordance with Section 8(c) of the Securities Act of 1933.
================================================================================
DEREGISTRATION OF SECURITIES
<PAGE>
DEREGISTRATION OF SECURITIES
----------------------------
On February 17, 1993, the Registration Statement on Form S-3 (File No.
33-57360) (the "Registration Statement") of Carrington Laboratories, Inc. (the
"Issuer") covering an aggregate of 495,040 shares of Common Stock, par value
$.01 per share (the "Common Stock"), of the Issuer to be sold from time to time
by certain shareholders of the Issuer, was declared effective by the Securities
and Exchange Commission (the "Commission").
Pursuant to the undertakings of the Issuer set forth in Part II of the
Registration Statement, the Issuer hereby deregisters the shares of Common Stock
covered by the Registration Statement that remain unsold as of the date of
filing hereof pursuant to this Post-Effective Amendment No. 1 to the
Registration Statement.
-2-
<PAGE>
SIGNATURES
----------
Pursuant to the requirements of the Securities Act of 1933, the
Registrant has duly caused this Post-Effective Amendment No. 1 to Form S-3
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Irving, State of Texas, on the 5th day of July,
1995.
CARRINGTON LABORATORIES, INC.
By: /s/ Christopher S. Record
----------------------------------------
Christopher S. Record, Vice President,
Finance and Administration
Pursuant to the requirements of the Securities Act of 1933, this Post-
Effective Amendment No. 1 to the Registration Statement has been signed by the
following persons in the capacities and on the dates indicated:
<TABLE>
<CAPTION>
Signature Title Date
- ----------- ----- ----
<S> <C> <C>
/s/ GEORGE DEMOTT Chairman of the Board July 5, 1995
- ---------------------------
George DeMott
/s/ CARLTON E. TURNER President, Chief Executive July 5, 1995
- ---------------------------
Carlton E. Turner Officer and Director
(Principal Executive Officer)
/s/ CHRISTOPHER S. RECORD Vice President, Finance and July 5, 1995
- ---------------------------
Christopher S. Record Administration (Principal
Financial and Accounting
Officer)
/s/ SELVI VESCOVI Director July 5, 1995
- ---------------------------
Selvi Vescovi
/s/ THOMAS J. MARQUEZ Director July 5, 1995
- ---------------------------
Thomas J. Marquez
</TABLE>
-3-
<PAGE>
<TABLE>
<S> <C> <C>
/s/ ROBERT A. FILDES
- --------------------------- Director July 5, 1995
Robert A. Fildes
/s/ JAMES T. O'BRIEN Director July 5, 1995
- ---------------------------
James T. O'Brien
/s/ R. DALE BOWERMAN Director July 5, 1995
- ---------------------------
R. DALE BOWERMAN
</TABLE>
-4-
